A Diagnostics & Imaging Week

Celerus Diagnostics (Carpinteria, California), a developer of rapid cancer diagnostics, reported the completion of $5 million in financing by private investors.

"We're delighted with the first closing of our Series C financing," said Dave Gross, newly named CEO of Celerus. "With this additional investment, we will further address market demand for rapid IHC (immunohistochemistry) testing and accelerate the commercialization of our onboard heating solution for the Celerus Wave."

The Celerus Wave system is designed to deliver precise, standardized histology and cytology results in 15 minutes. Intra-operative frozen tissue sections now undergo IHC staining regularly using the Wave system.

"By addressing the unmet needs of the anatomic pathology laboratory, the Celerus Wave provides real-time solutions for cancer patient management," said Gross.

The system is currently in use at numerous hospitals and reference laboratories across the country. The first Celerus Wave Systems were installed in North America and Europe in 2008.